Biogen Inc (NASDAQ:BIIB)

293.79
Delayed Data
As of Apr 01
 -23.11 / -7.30%
Today’s Change
215.78
Today|||52-Week Range
374.99
-0.99%
Year-to-Date
So Your Biotech Announced Positive Phase 3 Results? Celebrating Could be Premature
Apr 01 / MotleyFool.com - Paid Partner Content
Better Buy: AbbVie vs. Biogen
Mar 24 / MotleyFool.com - Paid Partner Content
4 Reasons Drug Stocks Are a Buy Right Now
Mar 30 / MotleyFool.com - Paid Partner Content
Are These Warren Buffett Stocks a Buy at Beaten-Down Prices?
Mar 23 / MotleyFool.com - Paid Partner Content
Bristol Myers Squibb's Multiple Sclerosis Drug, a Potential Blockbuster, Wins FDA Approval
Mar 26 / MotleyFool.com - Paid Partner Content
Berkshire’s Recent Purchases Show Why Value Investing Still Works
Mar 20 / MotleyFool.com - Paid Partner Content
4 Reasons Biotech Stocks Are a Buy Right Now
Mar 25 / MotleyFool.com - Paid Partner Content